Study on quality markers of ginseng acting on heart failure based on TCMIP V2.0
10.7501/j.issn.0253-2670.2019.19.015
- VernacularTitle: 基于TCMIP V2.0人参治疗心衰质量标志物研究
- Author:
Ru-Yi CUI
1
Author Information
1. Institute of Chinese Materia Medica, China Academy of Chinese Medicinal Sciences
- Publication Type:Journal Article
- Keywords:
Ginseng;
Heart failure;
Integrative pharmacology;
Q-marker;
Target
- From:
Chinese Traditional and Herbal Drugs
2019;50(19):4628-4633
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To predict the possible quality markers of ginseng in the treatment of heart failure. Methods: The ginseng chemical information was used to predict its putative targets related to heart failure by TCMIP V2.0 and the protein-protein interaction (PPI) network was constructed. The key targets of drug intervention on heart failure were enriched. The interaction network of chemical components-key targets-pathways was constructed to obtain the main components acting on these key targets, which are related to drug efficacy. According to the five principles of quality markers identification, we analyzed the quality markers of ginseng in the treatment of heart failure. Results: A total of 63 key targets were obtained for ginseng in the treatment of heart failure, including 63 putative drug targets and two targets related to disease. ATP1A1 and ADCY2 are the common targets associated with the drug and disease. The common targets of ATP1A1 and ADCY2 may be the key targets of drug acting on disease. The main components of ginseng acting on these common targets were screened out, and then we have determined the possible quality markers of ginseng for the treatment of heart failure based on the five principles of quality markers. Conclusion: We obtained the possible quality markers of ginseng in the treatment of heart failure, including ginsenoside Rg1, ginsenoside Re, ginsenoside Rf, and ginsenoside Rb2, which provided the basis for our deeper research of ginseng in the treatment of heart failure.
